JPWO2022246084A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2022246084A5 JPWO2022246084A5 JP2023571758A JP2023571758A JPWO2022246084A5 JP WO2022246084 A5 JPWO2022246084 A5 JP WO2022246084A5 JP 2023571758 A JP2023571758 A JP 2023571758A JP 2023571758 A JP2023571758 A JP 2023571758A JP WO2022246084 A5 JPWO2022246084 A5 JP WO2022246084A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- set forth
- acid sequence
- sequence set
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163190964P | 2021-05-20 | 2021-05-20 | |
| US63/190,964 | 2021-05-20 | ||
| US202263341771P | 2022-05-13 | 2022-05-13 | |
| US63/341,771 | 2022-05-13 | ||
| PCT/US2022/030068 WO2022246084A1 (en) | 2021-05-20 | 2022-05-19 | Sars-cov-2 polypeptides |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024521098A JP2024521098A (ja) | 2024-05-28 |
| JPWO2022246084A5 true JPWO2022246084A5 (enExample) | 2025-05-28 |
Family
ID=82321637
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023571758A Pending JP2024521098A (ja) | 2021-05-20 | 2022-05-19 | ＳＡＲＳ－ＣｏＶ－２ポリペプチド |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20220370601A1 (enExample) |
| EP (1) | EP4294440A1 (enExample) |
| JP (1) | JP2024521098A (enExample) |
| KR (1) | KR20240012394A (enExample) |
| AU (1) | AU2022277697A1 (enExample) |
| BR (1) | BR112023024034A2 (enExample) |
| CA (1) | CA3212678A1 (enExample) |
| IL (1) | IL308465A (enExample) |
| MX (1) | MX2023013665A (enExample) |
| WO (1) | WO2022246084A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024006362A1 (en) * | 2022-06-28 | 2024-01-04 | Transcode Therapeutics, Inc. | Nanoparticles and template directed rig-i agonist precursor compositions and uses thereof for cancer therapy |
| CN115947801A (zh) * | 2022-12-29 | 2023-04-11 | 中国疾病预防控制中心病毒病预防控制所 | 一种流感病毒通用和冠状病毒联合多肽及其疫苗的应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CR20220552A (es) * | 2020-04-02 | 2023-01-17 | Regeneron Pharma | Anticuerpos contra glicoproteína de espícula anti-sars-cov-2 y fragmentos de unión al antígeno |
| WO2021204179A1 (en) * | 2020-04-09 | 2021-10-14 | Suzhou Abogen Biosciences Co., Ltd. | Nucleic acid vaccines for coronavirus |
| WO2021214297A1 (en) * | 2020-04-23 | 2021-10-28 | Isa Pharmaceuticals B.V. | Immunization against sars-cov-related diseases |
| GB202011652D0 (en) * | 2020-07-28 | 2020-09-09 | Univ Oxford Innovation Ltd | Polypeptide panels and uses thereof |
| US11191827B1 (en) * | 2020-12-09 | 2021-12-07 | Tevogen Bio Inc. | COVID-19 peptide specific T-cells and methods of treating and preventing COVID-19 |
-
2022
- 2022-05-19 US US17/748,715 patent/US20220370601A1/en active Pending
- 2022-05-19 MX MX2023013665A patent/MX2023013665A/es unknown
- 2022-05-19 IL IL308465A patent/IL308465A/en unknown
- 2022-05-19 BR BR112023024034A patent/BR112023024034A2/pt unknown
- 2022-05-19 AU AU2022277697A patent/AU2022277697A1/en active Pending
- 2022-05-19 KR KR1020237039921A patent/KR20240012394A/ko active Pending
- 2022-05-19 JP JP2023571758A patent/JP2024521098A/ja active Pending
- 2022-05-19 WO PCT/US2022/030068 patent/WO2022246084A1/en not_active Ceased
- 2022-05-19 EP EP22735677.1A patent/EP4294440A1/en active Pending
- 2022-05-19 CA CA3212678A patent/CA3212678A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2020254535A1 (en) | Rotavirus mrna vaccine | |
| US20240370011A1 (en) | Compositions and methods of ribonucleic acid respiratory syncytial virus (rsv) vaccines | |
| CA2406100A1 (en) | Dna transfection system for the generation of infectious influenza virus | |
| JP2019519252A5 (enExample) | ||
| US20110110974A1 (en) | Methods and kits for inducing a ctl response using a prime boost regimen | |
| JP2002537844A (ja) | ヘルパーウイルス無しで安定な組換えインフルエンザウイルス | |
| CN111108192A (zh) | 非人类人猿腺病毒核酸序列和氨基酸序列、含有其的载体及其用途 | |
| WO2014205579A4 (en) | Modified matrix proteins of vesicular stomatitis virus | |
| JP2008514203A5 (enExample) | ||
| US20250339510A1 (en) | Polynucleotide vaccine formulations and methods of using the same | |
| US12280104B2 (en) | Composition and methods for MRNA vaccines against novel omicron coronavirus infections | |
| JPWO2022246084A5 (enExample) | ||
| Wahren | Gene vaccines | |
| WO2022260960A1 (en) | Virus-like particle vaccine for coronavirus | |
| JPWO2019016680A5 (enExample) | ||
| JP4797149B2 (ja) | インフルエンザウイルスに対するベクターワクチン | |
| CN107841513B (zh) | 基于M2e表位的广谱型流感疫苗 | |
| CN117338917A (zh) | 流感疫苗 | |
| CN117203243A (zh) | 用于预防rsv和piv3感染的组合物和方法 | |
| US20230201330A1 (en) | Virus-like particles containing RSV antigen protein and vaccines using the same | |
| CN112135908A (zh) | 选择性cd8阳性t细胞诱导疫苗抗原 | |
| CA2325345A1 (en) | Medicaments for inducing cytotoxic t-cells | |
| CN119264229A (zh) | 基于SARS-CoV-2的不同奥密克戎变异型的S蛋白的疫苗和组合物 | |
| TWI901715B (zh) | 大猩猩腺病毒核酸及胺基酸序列，包含彼之載體，及其用途 | |
| US9060973B2 (en) | Vaccine for enveloped viruses |